TGA Approval

CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial (125817)

ARTG ID

125817

ARTG Name

CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial

Sponsor

CSL Behring (Australia) Pty Ltd

ARTG Date

March 1, 2006

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Listed - Exempt

Sponsor Information

Sponsor Name

Sponsor Item Name

CSL BEHRING (AUSTRALIA) PTY LTD

Ingredient Name

tetanus immunoglobulin

Empowering clinical research with data-driven insights and AI-powered tools.

CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial (125817) - TGA 批准文号 | MedPath